| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BioXcel Therapeutics Inc (NASDAQ: BTAI)
BTAI Technical Analysis
3
| As on 9th Dec 2025 BTAI STOCK Price closed @ 2.13 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.99 & Buy for SHORT-TERM with Stoploss of 0.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BTAISTOCK Price
| Open | 2.21 | Change | Price | % |
| High | 2.24 | 1 Day | -0.07 | -3.18 |
| Low | 2.08 | 1 Week | -0.12 | -5.33 |
| Close | 2.13 | 1 Month | -0.15 | -6.58 |
| Volume | 435715 | 1 Year | 1.72 | 419.51 |
| 52 Week High 6.80 | 52 Week Low 0.16 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 184.97 | -0.31% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| PLUG | 2.21 | 2.31% |
| ONDS | 9.23 | 2.33% |
| LILM | 0.05 | 0.00% |
| PONO | 1.72 | 2.38% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BTAI Daily Charts |
BTAI Intraday Charts |
Whats New @ Bazaartrend |
BTAI Free Analysis |
|
|
BTAI Important Levels Intraday
| RESISTANCE | 2.44 |
| RESISTANCE | 2.34 |
| RESISTANCE | 2.28 |
| RESISTANCE | 2.22 |
| SUPPORT | 2.04 |
| SUPPORT | 1.98 |
| SUPPORT | 1.92 |
| SUPPORT | 1.82 |
BTAI Forecast December 2025
| 4th UP Forecast | 2.67 |
| 3rd UP Forecast | 2.5 |
| 2nd UP Forecast | 2.39 |
| 1st UP Forecast | 2.28 |
| 1st DOWN Forecast | 1.98 |
| 2nd DOWN Forecast | 1.87 |
| 3rd DOWN Forecast | 1.76 |
| 4th DOWN Forecast | 1.59 |
BTAI Weekly Forecast
| 4th UP Forecast | 2.52 |
| 3rd UP Forecast | 2.39 |
| 2nd UP Forecast | 2.32 |
| 1st UP Forecast | 2.24 |
| 1st DOWN Forecast | 2.02 |
| 2nd DOWN Forecast | 1.94 |
| 3rd DOWN Forecast | 1.87 |
| 4th DOWN Forecast | 1.74 |
BTAI Forecast2025
| 4th UP Forecast | 17.39 |
| 3rd UP Forecast | 12.5 |
| 2nd UP Forecast | 9.47 |
| 1st UP Forecast | 6.45 |
| 1st DOWN Forecast | -2.19 |
| 2nd DOWN Forecast | -5.21 |
| 3rd DOWN Forecast | -8.24 |
| 4th DOWN Forecast | -13.13 |
BioXcel Therapeutics Inc ( NASDAQ USA Symbol : BTAI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BTAI Business Profile
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic receptor agonist dexmedetomidine for the treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immune activator for the treatment of prostate and pancreatic cancers, and solid tumors. BioXcel Therapeutics, Inc. has a collaboration with collaboration with the VA Connecticut Healthcare System and the Yale University Medical School for patients suffering from post-traumatic stress disorder related to alcohol and substance abuse disorder. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut. Address: 555 Long Wharf Drive, New Haven, CT, United States, 06511
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service